Efficacy of 3,4-DAP in Fatigue Associated With Multiple Sclerosis

Update Il y a 4 ans
Reference: NCT00190268

Woman and Man

  • | Country :
  • France
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Rational of study : 3,4-diaminopyridine is suspected to improved the fatigue associated in patient's multiple sclerosis. In order to confirm this hypothesis, a randomized, controlled versus placebo, double blinded study is performed.


Inclusion criteria

  • Multiple sclerosis

Links